Isolation and expansion of resident cardiac progenitor cells

References

• American Heart Association, Heart Disease and Stroke Statistics – 2004 Update., TX, USA, American Heart Association, 2003
   Google Scholar
• Holmes JW, Borg TK, Covell JW. Structure and mechanics of healing myocardial infarcts. Annu. Rev. Biomed. Eng. 7, 223–253 (2005).
   PubMed Web of Science ®Google Scholar
• Smits AM, van Vliet P, Hassink RJ, Goumans MJ, Doevendans PA. The role of stem cells in cardiac regeneration. J. Cell. Mol. Med. 9(1), 25–36 (2005).
   PubMed Web of Science ®Google Scholar
• Zwaginga JJ, Doevendans P. Stem cell-derived angiogenic/vasculogenic cells: possible therapies for tissue repair and tissue engineering. Clin. Exp. Pharmacol. Physiol.30(11), 900–908 (2003).
   PubMed Web of Science ®Google Scholar
• Fukuda K, Yuasa S. Stem cells as a source of regenerative cardiomyocytes. Circ. Res.98(8), 1002–1013 (2006).
   PubMed Web of Science ®Google Scholar
• Makino S, Fukuda K, Miyoshi S et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest.103(5), 697–705 (1999).
   PubMed Web of Science ®Google Scholar
• Hakuno D, Fukuda K, Makino S et al. Bone marrow-derived regenerated cardiomyocytes (CMG Cells) express functional adrenergic and muscarinic receptors. Circulation105(3), 380–386 (2002).
   PubMed Web of Science ®Google Scholar
• Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation105(1), 93–98 (2002).
   PubMed Web of Science ®Google Scholar
• Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 410(6829), 701–705 (2001).
   PubMed Web of Science ®Google Scholar
• Murry CE, Soonpaa MH, Reinecke H et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428(6983), 664–668 (2004).
   PubMed Web of Science ®Google Scholar
• Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428(6983), 668–673 (2004).
   PubMed Web of Science ®Google Scholar
• Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature425(6961), 968–973 (2003).
   PubMed Web of Science ®Google Scholar
• Nygren JM, Jovinge S, Breitbach M et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med.10(5), 494–501 (2004).
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J. Clin. Invest.115(3), 572–583 (2005).
   PubMed Web of Science ®Google Scholar
• Murry CE, Field LJ, Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation112(20), 3174–3183 (2005).
   PubMed Web of Science ®Google Scholar
• Menasche P. Skeletal myoblast transplantation for cardiac repair. Expert. Rev. Cardiovasc. Ther. 2(1), 21–28 (2004).
   PubMedGoogle Scholar
• Passier R, Mummery C. Origin and use of embryonic and adult stem cells in differentiation and tissue repair. Cardiovasc. Res. 58(2), 324–335 (2003).
   PubMed Web of Science ®Google Scholar
• Moore JC, van Laake LW, Braam SR et al. Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies. Reprod. Toxicol.20(3), 377–391 (2005).
   PubMedGoogle Scholar
• Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ. Res.83(1), 15–26 (1998).
   PubMed Web of Science ®Google Scholar
• Beltrami AP, Urbanek K, Kajstura J et al. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med.344(23), 1750–1757 (2001).
   PubMed Web of Science ®Google Scholar
• Anversa P, Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature 415(6868), 240–243 (2002).
   PubMed Web of Science ®Google Scholar
• Harvey RP. Patterning the vertebrate heart. Nat. Rev. Genet.3(7), 544–556 (2002).
   PubMed Web of Science ®Google Scholar
• Olson EN, Schneider MD. Sizing up the heart: development redux in disease. Genes Dev.17(16), 1937–1956 (2003).
   PubMed Web of Science ®Google Scholar
• Zaffran S, Frasch M. Early signals in cardiac development. Circ. Res.91(6), 457–469 (2002).
   PubMedGoogle Scholar
• Franco D, Lamers WH, Moorman AF. Patterns of expression in the developing myocardium: towards a morphologically integrated transcriptional model. Cardiovasc. Res. 38(1), 25–53 (1998).
   PubMed Web of Science ®Google Scholar
• Masino AM, Gallardo TD, Wilcox CA, Olson EN, Williams RS, Garry DJ. Transcriptional regulation of cardiac progenitor cell populations. Circ. Res.95(4), 389–397 (2004).
   Google Scholar
• Cai CL, Liang X, Shi Y et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell.5(6), 877–889 (2003).
   PubMed Web of Science ®Google Scholar
• Yang L, Cai CL, Lin L et al. Isl1Cre reveals a common Bmp pathway in heart and limb development. Development 133(8), 1575–1585 (2006).
   Google Scholar
• Laugwitz KL, Moretti A, Lam J et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433(7026), 647–653 (2005).
   PubMed Web of Science ®Google Scholar
• Greider CW. Telomerase activity, cell proliferation, and cancer. Proc. Natl Acad. Sci. USA.95(1), 90–92 (1998).
   PubMed Web of Science ®Google Scholar
• Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med.183(4), 1797–1806 (1996).
   PubMed Web of Science ®Google Scholar
• Zhou S, Schuetz JD, Bunting KD et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med.7(9), 1028–1034 (2001).
   PubMed Web of Science ®Google Scholar
• Hierlihy AM, Seale P, Lobe CG, Rudnicki MA, Megeney LA. The post-natal heart contains a myocardial stem cell population. FEBS Lett.530(1–3), 239–243 (2002).
   PubMed Web of Science ®Google Scholar
• Martin CM, Meeson AP, Robertson SM et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev. Biol.265(1), 262–275 (2004).
   PubMed Web of Science ®Google Scholar
• Pfister O, Mouquet F, Jain M et al. CD31- but not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ. Res.97(1), 52–61 (2005).
   PubMed Web of Science ®Google Scholar
• van de Rijn M., Heimfeld S, Spangrude GJ, Weissman IL. Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family. Proc. Natl Acad. Sci. USA.86(12), 4634–4638 (1989).
   PubMed Web of Science ®Google Scholar
• Ronnstrand L. Signal transduction via the stem cell factor receptor/c-Kit. Cell Mol. Life Sci.61(19–20), 2535–2548 (2004).
   PubMed Web of Science ®Google Scholar
• Matsuura K, Nagai T, Nishigaki N et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J. Biol. Chem.279(12), 11384–11391 (2004).
   PubMed Web of Science ®Google Scholar
• Oh H, Bradfute SB, Gallardo TD et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl Acad. Sci. USA100(21), 12313–12318 (2003).
   PubMed Web of Science ®Google Scholar
• Wang X, Hu Q, Nakamura Y et al. The Role of Sca-1+/CD31- Cardiac Progenitor Cell Population in Postinfarction LV Remodeling. Stem Cells24(7), 1779–1788 (2006).
   PubMed Web of Science ®Google Scholar
• Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114(6), 763–776 (2003).
   PubMed Web of Science ®Google Scholar
• Linke A, Muller P, Nurzynska D et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc. Natl Acad. Sci. USA.102(25), 8966–8971 (2005).
   PubMed Web of Science ®Google Scholar
• Urbanek K, Rota M, Cascapera S et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ. Res.97(7), 663–673 (2005).
   PubMed Web of Science ®Google Scholar
• Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc. Natl Acad. Sci. USA.95(15), 8801–8805 (1998).
   PubMed Web of Science ®Google Scholar
• Urbanek K, Quaini F, Tasca G et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc. Natl Acad. Sci. USA100(18), 10440–10445 (2003).
   PubMed Web of Science ®Google Scholar
• Urbanek K, Torella D, Sheikh F et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc. Natl Acad. Sci. USA.102(24), 8692–8697 (2005).
   PubMed Web of Science ®Google Scholar
• Messina E, De Angelis L, Frati G et al. Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart. Circ. Res.95(9), 911–921 (2004).
   PubMed Web of Science ®Google Scholar
• Goumans MJ, de Boer TP, Smits A et al. Human cardiac progenitor cells are able to differentiate into cardiomyocytes in vitro. Circulation112(17), U106 (2005).
   Google Scholar
• Heng BC, Haider HK, Sim EK, Cao T, Ng SC. Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro. Cardiovasc. Res. 62(1), 34–42 (2004).
   PubMed Web of Science ®Google Scholar
• Mummery C, Ward-van Oostwaard D, Doevendans P et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation107(21), 2733–2740 (2003).
   PubMed Web of Science ®Google Scholar
• Kehat I, Khimovich L, Caspi O et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol.22(10), 1282–1289 (2004).
   PubMed Web of Science ®Google Scholar
• Fukuhara S, Tomita S, Yamashiro S et al. Direct cell-cell interaction of cardiomyocytes is key for bone marrow stromal cells to go into cardiac lineage in vitro.J. Thorac. Cardiovasc. Surg.125(6), 1470–1480 (2003).
   Google Scholar
• Rubart M, Pasumarthi KB, Nakajima H, Soonpaa MH, Nakajima HO, Field LJ. Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ. Res.92(11), 1217–1224 (2003).
   PubMed Web of Science ®Google Scholar
• Azhar M, Schultz JJ, Grupp I et al. Transforming growth factor beta in cardiovascular development and function. Cytokine Growth Factor Rev.14(5), 391–407 (2003).
   Google Scholar
• Yoon YS, Wecker A, Heyd L et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J. Clin. Invest.115(2), 326–338 (2005).
   PubMed Web of Science ®Google Scholar
• Fazel S, Cimini M, Chen L et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J. Clin. Invest.116(7), 1865–1877 (2006).
   PubMed Web of Science ®Google Scholar
• Uemura R, Xu M, Ahmad N, Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res.98(11), 1414–1421 (2006).
   PubMed Web of Science ®Google Scholar
• Mangi AA, Noiseux N, Kong D et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med.9(9), 1195–1201 (2003).
   PubMed Web of Science ®Google Scholar
• Gnecchi M, He H, Liang OD et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med.11(4), 367–368 (2005).
   PubMed Web of Science ®Google Scholar
• Gnecchi M, He H, Noiseux N et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 20(6), 661–669 (2006).
   PubMed Web of Science ®Google Scholar
• O'Neill BT, Abel ED. Akt1 in the cardiovascular system: friend or foe? J. Clin. Invest.115(8), 2059–2064 (2005).
   PubMed Web of Science ®Google Scholar
• Rosenblatt-Velin N, Lepore MG, Cartoni C, Beermann F, Pedrazzini T. FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes. J. Clin. Invest.115(7), 1724–1733 (2005).
   PubMed Web of Science ®Google Scholar
• Simons M, Ware JA. Therapeutic angiogenesis in cardiovascular disease. Nat. Rev. Drug Discov. 2(11), 863–871 (2003).
   PubMed Web of Science ®Google Scholar
• Nordlie MA, Wold LE, Simkhovich BZ, Sesti C, Kloner RA. Molecular aspects of ischemic heart disease: ischemia/reperfusion-induced genetic changes and potential applications of gene and RNA interference therapy. J. Cardiovasc. Pharmacol. Ther.11(1), 17–30 (2006).
   Google Scholar
• Behfar A, Zingman LV, Hodgson DM et al. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J.16(12), 1558–1566 (2002).
   PubMed Web of Science ®Google Scholar
• Beqqali A, Kloots J, Ward-van Oostwaard D, Mummery C, Passier R. Genome-wide transcriptional profiling of human embryonic stem cells differentiating to cardiomyocytes. Stem Cells24(8), 1956–1967 (2006).
   PubMed Web of Science ®Google Scholar
• Yoon YS, Johnson IA, Park JS, Diaz L, Losordo DW. Therapeutic myocardial angiogenesis with vascular endothelial growth factors. Mol. Cell Biochem. 264(1–2), 63–74 (2004).
   PubMedGoogle Scholar
• Lemos PA, Serruys PW, Sousa JE. Drug-eluting stents: cost versus clinical benefit. Circulation.107(24), 3003–3007 (2003).
   PubMed Web of Science ®Google Scholar
• Babensee JE, McIntire LV, Mikos AG. Growth factor delivery for tissue engineering. Pharm. Res. 17(5), 497–504 (2000).
   PubMed Web of Science ®Google Scholar
• Zimmermann WH, Melnychenko I, Wasmeier G et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med.12(4), 452–458 (2006).
   PubMed Web of Science ®Google Scholar
• Reinecke H, Zhang M, Bartosek T, Murry CE. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation100(2), 193–202 (1999).
   PubMed Web of Science ®Google Scholar
• Isner JM. Myocardial gene therapy. Nature 415(6868), 234–239 (2002).
   PubMed Web of Science ®Google Scholar
• Chang MG, Tung L, Sekar RB et al. Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model. Circulation113(15), 1832–1841 (2006).
   PubMed Web of Science ®Google Scholar
• Krause DS. Plasticity of marrow-derived stem cells. Gene Ther.9(11), 754–758 (2002).
   PubMedGoogle Scholar
• Quaini F, Urbanek K, Beltrami AP et al. Chimerism of the transplanted heart. N. Engl. J. Med.346(1), 5–15 (2002).
   PubMed Web of Science ®Google Scholar
• Laflamme MA, Myerson D, Saffitz JE, Murry CE. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ. Res.90(6), 634–640 (2002).
   PubMed Web of Science ®Google Scholar
• Laflamme MA, Murry CE. Regenerating the heart. Nat. Biotechnol.23(7), 845–856 (2005).
   PubMed Web of Science ®Google Scholar
• Metzger D, Feil R. Engineering the mouse genome by site-specific recombination. Curr. Opin. Biotechnol. 10(5), 470–476 (1999).
   Google Scholar